Placeholder Banner

Testimony on Intellectual Property Protections in the Life Sciences

June 7, 2023

The global IP framework has enabled lifesaving innovation and provides a reliable legal foundation for companies to voluntarily license their IP to enhance research collaborations and provide timely, equitable global access to safe and effective therapeutics.

Download Full Comments Below
bio_ip_testimony_6.6.23.pdf
Discover More
BIO Board Vice Chair and CEO of Amicus Therapeutics testified that the drug price controls in the Inflation Reduction Act harm drug research and development.
BIO joined with other groups in writing House and Senate Agriculture Committee leaders in support of agricultural research (FFAR) funding in the farm bill. 
In response to the agency's request for information (Docket No. FDA-2023-N-0743-0002), BIO provides detailed comments.